| Rosenow, Felix |
| Completed | 3 | 128 | Europe, Canada, US, RoW | Ganaxalone, Placebo | Marinus Pharmaceuticals, Marinus Pharmaceuticals Inc., Marinus Pharmaceuticals, Inc. | Tuberous Sclerosis Complex | 09/24 | 10/24 | | |
| Completed | 3 | 270 | Europe, Canada, Japan, US, RoW | Placebo, Soticlestat, TAK-935 | Takeda | Lennox Gastaut Syndrome (LGS) | 01/24 | 01/24 | | |
| Completed | 3 | 144 | Europe, Canada, Japan, US, RoW | Soticlestat, TAK-935, Placebo | Takeda | Dravet Syndrome (DS) | 04/24 | 04/24 | | |
| Recruiting | 3 | 400 | Europe, Canada, Japan, US, RoW | Soticlestat, TAK-935 | Takeda | Dravet Syndrome (DS), Lennox Gastaut Syndrome (LGS) | 05/26 | 05/26 | | |
| Recruiting | 2 | 50 | Europe | Bortezomib, Placebo, isotonic NaCl solution | Jena University Hospital, Federal Ministry of Education and Reserach (BMBF) | Autoimmune Encephalitis | 11/25 | 04/26 | | |
CENOR, NCT05747001: This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK |
|
|
| Completed | N/A | 319 | Europe | | Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research | Focal Onset Seizure, Epilepsy | 09/23 | 09/23 | | |
SENSEII/AROUSE, NCT05839418: Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE) |
|
|
| Recruiting | N/A | 3000 | Europe | | Erasme University Hospital | Status Epilepticus | 12/28 | 12/28 | | |
| Hamer, Hajo |
NCT05219617 / 2022-001256-42: Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults |
|
|
| Recruiting | 3 | 252 | Europe, US, RoW | Carisbamate | SK Life Science, Inc., SK Life Science, Inc | Seizures, Lennox Gastaut Syndrome | 06/25 | 06/26 | | |
NCT05814523: To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE) |
|
|
| Withdrawn | 3 | 70 | Europe, RoW | Ganaxolone, Placebo, Standard of care | Marinus Pharmaceuticals | Refractory Status Epilepticus | 08/24 | 08/24 | | |
CENOR, NCT05747001: This is a Retrospective Study on the Use of CENOBAMATE as Adjunctive Treatment in Patients Suffering From Epilepsy in Early Access Program in Germany, France and UK |
|
|
| Completed | N/A | 319 | Europe | | Aziende Chimiche Riunite Angelini Francesco S.p.A, Hippocrates Research | Focal Onset Seizure, Epilepsy | 09/23 | 09/23 | | |
| Enrolling by invitation | N/A | 400 | Europe, Canada, Japan, US, RoW | Stereoelectroencephalography (SEEG) | Duke University, Christian Doppler University Hospital | Epilepsy Intractable | 11/25 | 11/25 | | |
